Endothelin and the tumor microenvironment: a finger in every pie.
Cancer
endothelin
epithelial to mesenchymal transition
hypoxia
tumor microenvironment
Journal
Clinical science (London, England : 1979)
ISSN: 1470-8736
Titre abrégé: Clin Sci (Lond)
Pays: England
ID NLM: 7905731
Informations de publication
Date de publication:
05 Jun 2024
05 Jun 2024
Historique:
received:
08
03
2024
revised:
07
05
2024
accepted:
08
05
2024
medline:
24
5
2024
pubmed:
24
5
2024
entrez:
24
5
2024
Statut:
ppublish
Résumé
The tumor microenvironment (TME) plays a central role in the development of cancer. Within this complex milieu, the endothelin (ET) system plays a key role by triggering epithelial-to-mesenchymal transition, causing degradation of the extracellular matrix and modulating hypoxia response, cell proliferation, composition, and activation. These multiple effects of the ET system on cancer progression have prompted numerous preclinical studies targeting the ET system with promising results, leading to considerable optimism for subsequent clinical trials. However, these clinical trials have not lived up to the high expectations; in fact, the clinical trials have failed to demonstrate any substantiated benefit of targeting the ET system in cancer patients. This review discusses the major and recent advances of the ET system with respect to TME and comments on past and ongoing clinical trials of the ET system.
Identifiants
pubmed: 38785410
pii: 234477
doi: 10.1042/CS20240426
doi:
Substances chimiques
Endothelins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
617-634Subventions
Organisme : Institute for Lung Health (ILH)
Informations de copyright
© 2024 The Author(s).